minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 4.2 | ± 2.6 |
| Group 2 (30) - Hip Arthroscopy | 4.0 | ± 1.7 |
Last reviewed · How we verify
Opiate Prescribing Guidelines Following Hip Arthroscopy
NA trial testing Group 1 - Opiate Tablets post Hip Arthroscopy in Hip Injuries in 111 participants. Completed in 8 July 2020.
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 111 |
| Start date | 12 June 2018 |
| Primary completion | 21 February 2020 |
| Estimated completion | 8 July 2020 |
| Sites | 1 location across United States |
Northwestern University
Adults 18 to 89, any sex, with Hip Injuries. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 4.2 | ± 2.6 |
| Group 2 (30) - Hip Arthroscopy | 4.0 | ± 1.7 |
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 5.0 | ± 2.1 |
| Group 2 (30) - Hip Arthroscopy | 4.7 | ± 2.1 |
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 3.9 | ± 2.5 |
| Group 2 (30) - Hip Arthroscopy | 3.8 | ± 2.3 |
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 3.2 | ± 2.4 |
| Group 2 (30) - Hip Arthroscopy | 3.3 | ± 2.1 |
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 2.3 | ± 2.4 |
| Group 2 (30) - Hip Arthroscopy | 2.2 | ± 1.6 |
Number of prescribed narcotic pills taken in the preceding time period
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 3.0 | ± 2.2 |
| Group 2 (30) - Hip Arthroscopy | 2.4 | ± 2.5 |
Number of prescribed narcotic medication tablets taken in the preceding time period
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 5.2 | ± 5.7 |
| Group 2 (30) - Hip Arthroscopy | 4.9 | ± 5.9 |
Number of prescribed narcotic medication tablets taken in the preceding time period
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 10.4 | ± 15.9 |
| Group 2 (30) - Hip Arthroscopy | 8.8 | ± 9.3 |
Number of prescribed narcotic medication tablets taken in the preceding time period
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 10.5 | ± 16.5 |
| Group 2 (30) - Hip Arthroscopy | 9.2 | ± 11.1 |
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 57.0 | ± 2.2 |
| Group 2 (30) - Hip Arthroscopy | 27.6 | ± 2.5 |
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 54.8 | ± 5.7 |
| Group 2 (30) - Hip Arthroscopy | 25.1 | ± 5.9 |
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
| Group | Value | 95% CI |
|---|---|---|
| Group 1 (60) - Hip Arthroscopy | 49.6 | ± 15.9 |
| Group 2 (30) - Hip Arthroscopy | 22.3 | ± 8.4 |
The purpose of the study is to determine if opiates are required to achieve appropriate analgesia after hip arthroscopy in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess medications that are at risk for misuse, diversion and contribution to the opioid epidemic
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169113.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing